Surviving a brain bleed is only the beginning of recovery for many people. A major new analysis suggests that keeping blood pressure lower over the long term could sharply reduce the chance of another stroke after an intracerebral hemorrhage.
An intracerebral hemorrhage, often shortened to ICH, happens when a blood vessel bursts and blood leaks directly into brain tissue. It is one of the most dangerous types of stroke because the bleeding can quickly damage brain cells and increase pressure inside the skull.
High blood pressure is one of the biggest causes of this type of stroke. Over many years, excessive pressure can weaken small blood vessels in the brain, making them more likely to break.
People who survive an ICH remain at risk of another stroke and other heart and blood vessel problems. This makes preventing a second event an important part of long-term care.
Researchers combined information from four randomized controlled trials involving 2,944 adults who had experienced an ICH. Randomized trials are especially useful because participants receive different treatment approaches in a way designed to make the groups as comparable as possible.
Two of the studies tested set combinations of blood pressure medicines. The other two compared treatment plans that aimed for different blood pressure levels.
Participants were followed for as long as six years. During that time, 6.5% of people receiving more intensive blood pressure treatment had another stroke, compared with 10.4% of those receiving less intensive treatment or standard care.
That difference represented a 38% lower risk of recurrent stroke in the intensive-treatment group. The benefit appeared consistently across the studies included in the analysis.
The strongest effect involved another brain bleed. Intensive treatment was associated with about a 61% lower risk of recurrent intracerebral hemorrhage, suggesting that better control of pressure inside the arteries may be particularly important for preventing another bleeding stroke.
There was a clear difference in blood pressure between the groups during follow-up. Average systolic pressure, the top number in a blood pressure reading, was about 127 mm Hg with intensive treatment and 138 mm Hg with standard or less intensive care.
Importantly, lowering blood pressure more aggressively did not appear to increase serious health problems overall. Serious adverse events occurred in about 29% of people in the intensive group and 33% in the comparison group.
The researchers also found benefits among people whose blood pressure was already relatively low when they entered the studies. Among participants starting with systolic pressure of 130 mm Hg or lower, recurrent stroke occurred in 6.2% of the intensive-treatment group and 13.9% of the control group.
This result is important because many guidelines commonly use a blood pressure goal below 130/80 mm Hg for people at high cardiovascular risk. The analysis suggests that reaching that number does not necessarily remove all remaining stroke risk after a brain bleed.
Professor Craig Anderson of The George Institute for Global Health, senior author of the research, said stronger blood pressure management could play a central role in preventing another stroke. The researchers estimated that intensive treatment could prevent about 16 recurrent strokes for every 1,000 patients treated during the first year.
The meta-analysis was published in The Lancet Neurology in 2026. It included the TRIDENT study, led by The George Institute for Global Health, along with three other randomized trials that provided information on people with previous intracerebral hemorrhage.
The findings are especially important because ICH affects millions of people worldwide and its burden is particularly heavy in lower-income countries, where high blood pressure is often poorly controlled. Simple, affordable and reliable ways to improve blood pressure treatment could therefore have a large public-health effect.
The study has several strengths, including randomized trial data, almost 3,000 participants and follow-up lasting several years. Combining trials also allowed researchers to examine whether the benefit differed according to starting blood pressure or the time since the original brain bleed.
However, this analysis does not mean every ICH survivor should immediately aim for the lowest possible blood pressure. Treatment must be individualized because age, medicines, dizziness, kidney health and other medical conditions can affect how safely a person tolerates lower pressure.
Overall, the evidence makes a strong case that long-term blood pressure control deserves close attention after a brain bleed. The most useful message is not simply that ‘lower is always better,’ but that carefully managed, sustained treatment may prevent many repeat strokes without an obvious increase in serious side effects.
If you care about stroke, please read studies that diets high in flavonoids could help reduce stroke risk, and MIND diet could slow down cognitive decline after stroke.
For more health information, please see recent studies about antioxidants that could help reduce the risk of dementia, and tea and coffee may help lower your risk of stroke, dementia.
Source: The George Institute for Global Health.
